PLANNED DENIAL | FDA’s Shifting Standards for Vape Authorization | RegWatch

2026-03-17

Nicotine regulation in the United States has entered a strange phase. The FDA says it’s protecting public health. But in practice, it’s blocking safer nicotine products while leaving deadly cigarettes on the market. In Part 1 of this RegWatch special, independent scientist Dr. Ian Fearon breaks down the mechanics behind that contradiction. From the overwhelming volume of PMTA applications to the agency’s shifting standards and mass denials, Fearon exposes a regulatory system struggling to keep pace with innov...

In Part 1 of this RegWatch special, independent scientist Dr. Ian Fearon breaks down the mechanics behind that contradiction. From the overwhelming volume of PMTA applications to the agency’s shifting standards and mass denials, Fearon exposes a regulatory system struggling to keep pace with innovation.

*Watch Part 2 | Friday March 20 | Only on GFN.TV

We examine the so-called “fatal flaw” that blindsided manufacturers, the rise of a massive illicit market, and the irrefutable collapse in youth vaping, even as vaping product availability exploded. So why hasn’t the FDA adjusted course?

Find out. Only on RegWatch by RegulatorWatch.com.

Released: March 17, 2026
Produced by: Brent Stafford

https://youtu.be/hdGmo1FBCGU

This episode is supported by DEMAND VAPE.

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

#RegWatch #VapeNews

Comments (3)